Target and Lead Identification and Optimization are the first steps of the drug discovery process. The process begins with identifying the target gene involved in the disease. After the target is located, scientists identify many molecules that show promising binding capabilities with the target protein or gene. Once a select few leads are chosen, those molecules are enhanced and altered to optimize factors such as potency, minimal toxicity, and selectivity.
Regularly, lead identification and optimization can be a very time consuming process, taking years to perfect the leads in order to move forward in the drug discovery process. In order to limit the financial and time cost of lead identification and optimization, industrious Western companies are turning to countries with lower costs to conduct this work. India has a plethora of talented scientists and facilities that can help minimize the costs of this vital step in the drug discovery process.
Furthermore, companies are providing artificial intelligence tools to allow drugs to come to market faster, by predicting structures of proteins and moving some aspects of the process to a virtual space. AI is a rapidly growing field in India. India is among the top 5 countries with the fastest-growing AI talent, according to a LinkedIn Report.
Companies in multiple locations in India are knowledgeable and experienced in Target and Lead ID and Optimization. Amritt Inc is familiar with such companies. You can trust our team to help you navigate using Indian companies to aid in your drug discovery process.